Streptococcus pyogenes Forms Serotype- and Local Environment-Dependent Interspecies Protein Complexes.

DIA-MS M proteins Streptococcus pyogenes XL-MS host-pathogen interactions protein-protein interactions

Journal

mSystems
ISSN: 2379-5077
Titre abrégé: mSystems
Pays: United States
ID NLM: 101680636

Informations de publication

Date de publication:
26 Oct 2021
Historique:
pubmed: 29 9 2021
medline: 29 9 2021
entrez: 28 9 2021
Statut: ppublish

Résumé

Streptococcus pyogenes is known to cause both mucosal and systemic infections in humans. In this study, we used a combination of quantitative and structural mass spectrometry techniques to determine the composition and structure of the interaction network formed between human plasma proteins and the surfaces of different S. pyogenes serotypes. Quantitative network analysis revealed that S. pyogenes forms serotype-specific interaction networks that are highly dependent on the domain arrangement of the surface-attached M protein. Subsequent structural mass spectrometry analysis and computational modeling of one of the M proteins, M28, revealed that the network structure changes across different host microenvironments. We report that M28 binds secretory IgA via two separate binding sites with high affinity in saliva. During vascular leakage mimicked by increasing plasma concentrations in saliva, the binding of secretory IgA was replaced by the binding of monomeric IgA and C4b-binding protein (C4BP). This indicates that an upsurge of C4BP in the local microenvironment due to damage to the mucosal membrane drives the binding of C4BP and monomeric IgA to M28. These results suggest that S. pyogenes has evolved to form microenvironment-dependent host-pathogen protein complexes to combat human immune surveillance during both mucosal and systemic infections.

Identifiants

pubmed: 34581598
doi: 10.1128/mSystems.00271-21
pmc: PMC8547449
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0027121

Subventions

Organisme : Alfred Österlunds Stiftelse (Alfred Österlunds Foundation)
Organisme : EC | H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (MSCA)
ID : Viral and Bacterial Adhesin Network Training (ViBrANT) Program 765042
Organisme : Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)
ID : 2016.0023
Organisme : Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)
ID : 2019.0353
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)
ID : P2ZHP3_191289
Organisme : Vetenskapsrådet (VR)
ID : 2019-01646

Références

Clin Microbiol Rev. 1989 Jul;2(3):285-314
pubmed: 2670192
Science. 2020 Feb 28;367(6481):1008-1014
pubmed: 32029686
J Biol Chem. 2012 Jan 6;287(2):1415-25
pubmed: 22117078
BMC Bioinformatics. 2011 Dec 08;12:468
pubmed: 22151573
J Immunol. 2002 Aug 1;169(3):1357-64
pubmed: 12133959
J Infect Dis. 2014 Oct 15;210(8):1325-38
pubmed: 24799598
J Immunol. 1995 Jan 1;154(1):375-86
pubmed: 7995956
J Immunol. 2000 May 15;164(10):5328-36
pubmed: 10799895
Mol Microbiol. 2006 Jan;59(1):20-30
pubmed: 16359315
Biochem J. 1994 Jun 15;300 ( Pt 3):877-86
pubmed: 8010973
PLoS Comput Biol. 2021 Jan 7;17(1):e1008169
pubmed: 33411763
Nat Biotechnol. 2014 Mar;32(3):219-23
pubmed: 24727770
J Immunol. 1996 Oct 1;157(7):3021-9
pubmed: 8816411
Clin Infect Dis. 2002 Sep 15;35(6):665-70
pubmed: 12203162
J Immunol. 1994 Oct 15;153(8):3557-64
pubmed: 7930578
J Exp Med. 1965 May 1;121:849-59
pubmed: 14278234
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9515-20
pubmed: 27512043
Trends Microbiol. 2010 Jun;18(6):275-82
pubmed: 20347595
Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S29-S41
pubmed: 28183813
Nat Biotechnol. 2012 Oct;30(10):918-20
pubmed: 23051804
Nat Methods. 2016 Sep;13(9):777-83
pubmed: 27479329
Curr Top Microbiol Immunol. 2013;368:1-27
pubmed: 23242849
Anal Chem. 2002 Oct 15;74(20):5383-92
pubmed: 12403597
Clin Infect Dis. 2003 Nov 1;37(9):1189-93
pubmed: 14557963
J Med Microbiol. 1993 Sep;39(3):165-78
pubmed: 8366514
Nat Rev Microbiol. 2003 Dec;1(3):219-30
pubmed: 15035026
J Biol Chem. 2006 Feb 10;281(6):3690-7
pubmed: 16330538
Clin Microbiol Infect. 2013 May;19(5):E222-9
pubmed: 23464795
EMBO J. 2002 Apr 2;21(7):1607-15
pubmed: 11927545
Mol Microbiol. 2000 Sep;37(6):1318-26
pubmed: 10998165
Rapid Commun Mass Spectrom. 2003;17(20):2310-6
pubmed: 14558131
EMBO J. 2001 Jun 15;20(12):3046-55
pubmed: 11406581
Nat Methods. 2008 Oct;5(10):873-5
pubmed: 18806791
Curr Opin Struct Biol. 2006 Apr;16(2):183-93
pubmed: 16546374
Biochem J. 1990 Oct 15;271(2):285-96
pubmed: 2241915
Proteomics. 2012 Apr;12(8):1111-21
pubmed: 22577012
Biol Chem. 2011 Dec;392(12):1077-88
pubmed: 22050223
Front Immunol. 2019 Jun 04;10:1230
pubmed: 31214187
Biochemistry. 2006 Apr 11;45(14):4559-68
pubmed: 16584191
Nat Commun. 2016 Jan 06;7:10261
pubmed: 26732734
Med Microbiol Immunol. 2020 Jun;209(3):265-275
pubmed: 32072248
Epidemiol Infect. 1988 Apr;100(2):257-69
pubmed: 3128449
Mol Cell Proteomics. 2014 Jun;13(6):1537-42
pubmed: 24677029
Mol Cell Proteomics. 2018 Jun;17(6):1097-1111
pubmed: 29511047
Nat Commun. 2019 Jan 14;10(1):192
pubmed: 30643114
Infect Immun. 1998 Oct;66(10):4593-601
pubmed: 9746555
J Immunol. 2001 Oct 1;167(7):3870-7
pubmed: 11564804
PLoS Pathog. 2006 May;2(5):e47
pubmed: 16733543
Mol Immunol. 1991 Apr-May;28(4-5):349-57
pubmed: 2062317
Infect Immun. 1979 Jul;25(1):1-10
pubmed: 383609
Adv Exp Med Biol. 1997;418:537-43
pubmed: 9331709
Nat Microbiol. 2016 Sep 05;1(11):16155
pubmed: 27595425
J Exp Med. 2003 Oct 6;198(7):1057-68
pubmed: 14517274
J Exp Med. 2012 Dec 17;209(13):2367-81
pubmed: 23230002
Infect Immun. 1992 Jun;60(6):2147-52
pubmed: 1587582
Clin Infect Dis. 2002 Jan 1;34(1):28-38
pubmed: 11731942
J Biol Chem. 2001 Mar 16;276(11):8197-204
pubmed: 11096107
Nat Methods. 2020 Jul;17(7):665-680
pubmed: 32483333
J Proteome Res. 2004 Sep-Oct;3(5):958-64
pubmed: 15473683
Structure. 2013 Oct 8;21(10):1735-42
pubmed: 24035711
Infect Immun. 1997 Jan;65(1):64-71
pubmed: 8975893
J Immunol. 2018 May 15;200(10):3495-3505
pubmed: 29626087
PLoS One. 2009 Oct 01;4(10):e7279
pubmed: 19794915
Immunol Lett. 2016 Jan;169:82-92
pubmed: 26658464
Nature. 2011 Apr 7;472(7341):64-8
pubmed: 21475196
Trends Microbiol. 2018 Feb;26(2):132-144
pubmed: 28867148
Biochemistry. 1997 Jul 1;36(26):8107-13
pubmed: 9201959
J Biol Chem. 1994 May 6;269(18):13458-64
pubmed: 8175778
Nat Commun. 2019 Jun 21;10(1):2727
pubmed: 31227708

Auteurs

Sounak Chowdhury (S)

Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund Universitygrid.4514.4, Lund, Sweden.

Hamed Khakzad (H)

Equipe Signalisation Calcique et Infections Microbiennes, Ecole Normale Supérieure Paris-Saclay, Gif-sur-Yvette, France.
Institut National de la Santé et de la Recherche Médicale U1282, Gif-sur-Yvette, France.

Gizem Ertürk Bergdahl (GE)

Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund Universitygrid.4514.4, Lund, Sweden.

Rolf Lood (R)

Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund Universitygrid.4514.4, Lund, Sweden.

Simon Ekstrom (S)

BioMS, Lund, Sweden.

Dirk Linke (D)

Department of Biosciences, Section for Genetics and Evolutionary Biology, University of Oslo, Oslo, Norway.

Lars Malmström (L)

Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund Universitygrid.4514.4, Lund, Sweden.

Lotta Happonen (L)

Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund Universitygrid.4514.4, Lund, Sweden.

Johan Malmström (J)

Division of Infection Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund Universitygrid.4514.4, Lund, Sweden.
BioMS, Lund, Sweden.

Classifications MeSH